dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:18:13Z
dc.date.available2014-05-27T11:18:13Z
dc.date.created2014-05-27T11:18:13Z
dc.date.issued1997-04-15
dc.identifierRenal Failure, v. 19, n. 2, p. 259-265, 1997.
dc.identifier0886-022X
dc.identifierhttp://hdl.handle.net/11449/65089
dc.identifier10.3109/08860229709026286
dc.identifier2-s2.0-0030909487
dc.identifier5496411983893479
dc.identifier5697804493071661
dc.identifier0000-0003-4979-4836
dc.description.abstractIn order to evaluate the role of underlying disease in the high mortality observed in acute renal failure (ARF) and risk factors related to the development of oliguric ARF in renal allograft recipients, two groups were selected: 34 patients with native kidneys, aged 16 and 57 years, and presenting ischemic ARF caused by cardiovascular collapse, with no signs of infection at the time of diagnosis; and 34 renal allograft recipients who developed ARF immediately after transplantation, without rejection. ARF was defined either as 30% increase of basal plasmatic creatinine in patients with native kidneys or non-normalization of plasmatic creatinine at day 5 after transplantation in renal allograft recipients; oliguria as diuresis ≤ 400 mL/24 h. There were no differences in age, male frequency, oliguria presence and duration, need for dialysis, and infection episodes for renal allograft recipients and patients with native kidneys. The development of sepsis (3% and 41%) and death rate (3% and 44%) were higher in patients with native kidneys (p < 0.01). The renal allograft recipients with both oliguric (n = 18) and nonoliguric (n = 16) ARF were evaluated and no difference was observed in the recipient's age, donor's age, cold ischemia time, time elapsed until plasmatic creatinine normalization, donor's plasmatic creatinine or urea, and mean arterial pressure. No differences were observed between the groups regarding frequency of infection episodes during ARF and frequency of death. In conclusion, renal allograft recipients presented a lower death rate and were less susceptible to sepsis. Cold ischemia time, age, and hemodynamic characteristics of the donor did not affect the development of oliguria.
dc.languageeng
dc.relationRenal Failure
dc.relation1.440
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectcreatinine
dc.subjectacute kidney failure
dc.subjectadolescent
dc.subjectadult
dc.subjectconference paper
dc.subjectcontrolled study
dc.subjectdialysis
dc.subjectfemale
dc.subjecthuman
dc.subjectkidney allograft
dc.subjectkidney ischemia
dc.subjectkidney transplantation
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmortality
dc.subjectoliguria
dc.subjectpriority journal
dc.subjectrecipient
dc.subjectsepsis
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAge Distribution
dc.subjectBrazil
dc.subjectEvaluation Studies
dc.subjectFemale
dc.subjectGraft Rejection
dc.subjectHumans
dc.subjectIncidence
dc.subjectKidney Failure, Acute
dc.subjectKidney Transplantation
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectRisk Factors
dc.subjectSex Distribution
dc.subjectSurvival Rate
dc.titleAcute renal failure in renal allograft recipients and patients with native kidneys
dc.typeActas de congresos


Este ítem pertenece a la siguiente institución